Table 2.
Sex hormone of 5 patients with 17-βHSD3 deficiency at following-up.
| Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | |
|---|---|---|---|---|---|
| E2 pmol/ml | 67.8 (<158) | 60.3 (<158) | <59.5 (<108) | <59.5 (<108) | |
| DHEA (umol/l) | 5.7 (0.55-3.37) | 7.33 (0.55-3.37) | <0.14 (<0.14) | <0.14 (<0.14) | |
| AND (nmol/l) | 26.8 (1.41-5.5) | 12 (1.41-5.5) | <1.05 (<1.05) | <1.05 (<1.05) | |
| T (nmol/l) | 4.72 (0.87-13.27) | 2.68 (0.87-13.27) | <0.69 (<0.69) | <0.69 (<0.69) | |
| LH (mIU/mL) | 20.5 (0.8-10.1) | 22.8 (0.8-10.1) | 0.23 (0.1-0.27) | <0.10 (0.1-0.27) | |
| FSH (mIU/mL) | 39.9 (1.8-9.6) | 39.5 (1.8-9.6) | 1.72 (0.2-0.85) | 0.78 (0.2-0.85) | |
| T/AND | 0.18 | 0.22 | <50 (≤50) | <50 (≤50) | |
| T basal level (nmol/l) | 4.72 | 2.68 | <0.69 | <0.69 | |
| T after HCG (nmol/l) | 5.62 | 11.8 | 9.19 | 4.4 | |
| AND basal level (nmol/l) | 26.8 | 12.3 | <1.05 | <1.05 | |
| AND after HCG (nmol/l) | 27.10 | 15.2 | 5.88 | 2.61 | |
| DHT basal level (pg/ml) | 531.73 | ||||
| DHT after HCG (pg/ml) | 739.52 | ||||
| T/AND basal level | 0.18 | 0.21 | – | – | |
| T/AND after HCG | 0.21 | 0.78 | 1.56 | 1.68 |